These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 5309528)

  • 1. Serum antibacterial activity after oral suspensions and capsules of triacetyloleandomycin and erythromycin estolate.
    Saslaw S; Carlisle HN
    Appl Microbiol; 1970 Feb; 19(2):370-4. PubMed ID: 5309528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of staphylococcal infections in monkeys. IV. Further comparison of triacetyloleandomycin and erythromycins.
    Saslaw S; Carlisle HN; Marietti M
    Appl Microbiol; 1969 Dec; 18(6):1077-83. PubMed ID: 4984259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antistaphylococcic activity, protective activity in vivo and blood levels in man of triacetyl-oleandomycin and erythromycin].
    Colitti G; Liani M; Stella F
    Antibiotica; 1970; 8(2):216-25. PubMed ID: 5317332
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma bactericidal activity after administration of erythromycin estolate and erythromycin ethylsuccinate to healthy volunteers.
    Bérubé D; Kirouac D; Croteau D; Bergeron MG; Lebel M
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1227-30. PubMed ID: 3142349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-hemolytic streptococcal illness. A comparison of the effectiveness of penicillin G, triacetyloleandomycin, and erythromycin estolate.
    Breese BB; Disney FA; Talpey WB
    Am J Dis Child; 1966 Feb; 111(2):128-32. PubMed ID: 5322797
    [No Abstract]   [Full Text] [Related]  

  • 6. Concentrations of erythromycin in serum and tonsil: comparison of the estolate and ethyl succinate suspensions.
    Ginsburg CM; McCracken GH; Culbertson MC
    J Pediatr; 1976 Dec; 89(6):1011-3. PubMed ID: 792404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels following single and repeated doses of erythromycin estolate and erythromycin stearate.
    Welling PG; Elliott RL; Pitterle ME; Corrick-West HP; Lyons LL
    J Pharm Sci; 1979 Feb; 68(2):150-5. PubMed ID: 423080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibacterial activity in vitro and in vivo and blood levels in man of two antibiotics of the macrolid group: lincomycin and triacetyloleandomycin].
    Ciaffi G; Colitti A; Renzini G
    Antibiotica; 1970; 8(2):206-15. PubMed ID: 4949768
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of the bioavailabilities of erythromycin estolate and erythromycin ethylsuccinate dry suspension preparations in steady state].
    Potthast H; Schug B; Elze M; Schwerdtle R; Blume H
    Pharmazie; 1995 Jan; 50(1):56-60. PubMed ID: 7886126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical use of chewable triacetyloleandomycin tablets (Matromycin T chewable)].
    Imai M; Takahashi T; Namba K
    J Antibiot B; 1967 Oct; 20(5):347-50. PubMed ID: 5300955
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative bioavailability evaluation of erythromycin base and its salts and esters. I. Erythromycin estolate capsules versus enteric-coated erythromycin base tablets.
    DiSanto AR; Tserng KY; Chodos DJ; DeSante KA; Albert KS; Wagner JG
    J Clin Pharmacol; 1980 Jul; 20(7):437-43. PubMed ID: 7430412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THE CONSISTENCY OF IN VITRO MICROBIAL RESPONSE: A SURVEY OF THE AMERICAS, EUROPE AND JAPAN.
    ISENBERG HD
    Health Lab Sci; 1965 Jul; 2():163-78. PubMed ID: 14318054
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral administration of erythromycin stearate: effect of dosage form on plasma levels.
    Triggs EJ; Ashley JJ
    Med J Aust; 1978 Jul; 2(3):121-3. PubMed ID: 713930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five days of erythromycin estolate versus ten days of penicillin V in the treatment of group A streptococcal tonsillopharyngitis in children. Pharyngitis Study Group.
    Adam D; Scholz H
    Eur J Clin Microbiol Infect Dis; 1996 Sep; 15(9):712-7. PubMed ID: 8922570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography.
    Croteau D; Bergeron MG; LeBel M
    Antimicrob Agents Chemother; 1988 Apr; 32(4):561-5. PubMed ID: 3259856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptococcal pharyngitis therapy. A comparison of two erythromycin formulations.
    Derrick CW; Dillon HC
    Am J Dis Child; 1979 Nov; 133(11):1146-8. PubMed ID: 389036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age.
    Patamasucon P; Kaojarern S; Kusmiesz H; Nelson JD
    Antimicrob Agents Chemother; 1981 May; 19(5):736-9. PubMed ID: 6975059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of staphylococcal infections in monkeys. VI. Comparison of clindamycin, erythromycin, and methicillin.
    Carlisle HN; Saslaw S
    Appl Microbiol; 1971 Mar; 21(3):440-6. PubMed ID: 4994902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythromycin estolate in general practice. A comparative trial of two dosage forms.
    Grainger GJ
    Practitioner; 1969 Jul; 202(213):84-6. PubMed ID: 4895696
    [No Abstract]   [Full Text] [Related]  

  • 20. Selection of an oral erythromycin product.
    Fraser DG
    Am J Hosp Pharm; 1980 Sep; 37(9):1199-205. PubMed ID: 6998290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.